These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8896670)
1. Relevance of the trough-to-peak ratio to the 24 h blood pressure load. White WB Am J Hypertens; 1996 Oct; 9(10 Pt 2):91S-96S; discussion 108S-109S. PubMed ID: 8896670 [TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy. White WB; Lund-Johansen P; Omvik P J Hypertens Suppl; 1993 Jun; 11(4):S75-80. PubMed ID: 8377035 [TBL] [Abstract][Full Text] [Related]
3. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring? Neutel JM; Smith DH; Weber MA Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419 [TBL] [Abstract][Full Text] [Related]
4. Trough-to-peak versus surface ratio in the assessment of antihypertensive agents. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension. Bieniaszewski L; Staessen JA; Byttebier G; De Leeuw P; Van Hedent T; Fagard R Blood Press; 1995 Nov; 4(6):350-7. PubMed ID: 8746602 [TBL] [Abstract][Full Text] [Related]
5. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs. Zannad F J Hypertens Suppl; 1995 Aug; 13(2):S109-12. PubMed ID: 8576780 [TBL] [Abstract][Full Text] [Related]
6. The use of Fourier analysis in the calculation of trough to peak ratio from ambulatory blood pressure measurements. Diamant M; Idema RN; Vincent HH J Hum Hypertens; 1998 Jan; 12(1):61-7. PubMed ID: 9482136 [TBL] [Abstract][Full Text] [Related]
14. Analysis of ambulatory blood pressure data in antihypertensive drug trials. White WB J Hypertens Suppl; 1991 Jan; 9(1):S27-32. PubMed ID: 2040903 [TBL] [Abstract][Full Text] [Related]
15. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
17. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group. Zanchetti A J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282 [TBL] [Abstract][Full Text] [Related]
18. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC; Ayala DE; Fernández JR; Mojón A Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592 [TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. White WB; Lacourciere Y; Davidai G Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]